Point-of-care diagnostics for HIV and tuberculosis: Landscape, Pipeline, and Unmet Needs

Discovery Medicine

Volumn 13, Issue 68, 2013, Pages 35-45

  Pai, Nitika Pant ^a   Pai, Madhukar ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOSPITAL INFORMATION SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; TUBERCULOSIS;

HIV INFECTIONS; HUMANS; POINT-OF-CARE SYSTEMS; TUBERCULOSIS;

EID: 84860003715     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Jr, Dye C, Halloran ME. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 106(33):13980-13985, 2009.
2. Batz H-G, Cooke GS, Reid SD. Towards Lab-free Tuberculosis Diagnosis. pp. 1-36. Treatment Action Group, Stop TB Partnership, Imperial College London, and Médecins Sans Frontières, New York, New York, USA, 2011.
3. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, Koulchin V, Hoelscher M. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 99(12): 893-900, 2005
4. Boyle DS, Hawkins KR, Steele MS, Singhal M, Cheng X Emerging technologies for point-of-care CD4 T-lymphocyte counting. Trends Biotechnol 30(1):45-54, 2012.
5. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, Makombe SD, Chunda T, Squire SB, French N, Mwapasa V, Corbett EL. The Uptake and Accuracy of Oral Kits for HIV Self-Testing in High HIV Prevalence Setting: A Cross-Sectional Feasibility Study in Blantyre, Malawi. PLoS Med 8(10):e1001102, 2011.
6. Delaney KP, Branson BM, Uniyal A, Phillips S, Candal D, Owen SM, Kerndt PR. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis 52(2):257-263, 2011.
7. Denkinger CM, Pai M. Point-of-care tuberculosis diagnosis: are we there yet? Lancet Infect Dis, epub ahead of print, Oct. 17, 2011.
8. Dowdy DW, O'brien MA, Bishai D. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12(9):1021-1029, 2008.
9. Dowdy DW, Steingart KR, Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 8(8):e1001074, 2011.
10. Engel N, Kenneth J, Pai M. TB diagnostics in India: creating an ecosystem for innovation. Expert Rev Mol Diagn 12(1):21-24, 2012.
11. Estrin D, Sim I. Health care delivery. Open mHealth architecture: an engine for health care innovation. Science 330(6005):759-760, 2010.
12. Flores L, Steingart K, Dendukuri N, Schiller I, Minion J, Pai M, Ramsay A, Henry M, Laal S. Antigen detection tests for the diagnosis of tuberculosis: A systematic review and meta-analysis. Clin Vaccine Immunol 18(10):1616-1627, 2011.
13. Frew SE, Kettler HE, Singer PA. The Indian and Chinese health biotechnology industries: potential champions of global health? Health Aff (Millwood) 27(4):1029-1041, 2008.
14. Grenier J, Pinto LM, Nair D, Steingart KR, Dowdy DW, Ramsay A, Pai M. Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Resp J 39(2):502-505, 2012
15. Harrington M From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis 50(Suppl 3):S260-S266, 2010.
16. Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med 8(6):e1001045, 2011.
17. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J, Aledort JE, Hillborne L, Rafael ME, Girosi F, Dye C. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444(Suppl 1):49-57, 2006.
18. Lawn SD, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 4(4):325-333, 2009.
19. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Screening for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy: diagnostic accuracy of a low-cost, urine antigen, point-of-care assay (Determine TB-LAM Ag): a descriptive study. Lancet Infect Dis, epub ahead of print, Oct. 17, 2011.
20. Lemaire JF, Casenghi M. New diagnostics for tuberculosis: fulfilling patient needs first. J Int AIDS Soc 13:40, 2010.
21. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J 38(6):1398-1405, 2011.
22. Murtagh M. UNITAID Technical Report. HIV/AIDS Diagnostic Landscape. UNITAID, Geneva, Switzerland, 2011.
23. Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 29(5):240-250, 2011.
24. Pai M. Diagnosing tuberculosis: Can India take the lead? In: PloS Medicine Speaking of Medicine. 2011a. http://blogs.plos.org/speakingofmedicine/2011/09/28/diagnosing-tuberculosis-can-india-take-the-lead/. (Accessed Oct. 31, 2011.)
25. Pai M. Improving TB diagnosis: difference between knowing the path and walking the path. Expert Rev Mol Diagn 11(3):241-244, 2011b.
26. Pai NP, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, Peeling RW, Joseph L. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis, epub ahead of print, Jan. 24, 2012.
27. Pai NP, Barick R, Tulsky JP, Shivkumar PV, Cohan D, Kalantri S, Pai M, Klein MB, Chhabra S. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med 5(5):e92, 2008.
28. Pai NP, Klein MB. Are we ready for home-based, self-testing for HIV?. Future HIV Therapy 2(6):515-520, 2008.
29. Pai NP, Klein MB. Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challenges. Womens Health 5(1):55-62, 2009.
30. Pai NP, Tulsky JP, Cohan D, Colford JM, Jr, Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop Med Int Health 12(2):162-173, 2007.
31. Pant Pai N, Joshi R, Dogra S, Taksande B, Kalantri SP, Pai M, Narang P, Tulsky JP, Reingold AL. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One 2(4):e367, 2007.
32. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 16(8):1062-1069, 2010.
33. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 16(3):262-270, 2010.
34. Peter J, Haripesad A, Mottay L, Kraus S, Meldau R, Dheda K. The Clinical Utility Of Urine Lipoarabinomannan And The Novel Point-Of-Care Lateral Flow Strip Test (Determine® TB) For The Diagnosis Of Tuberculosis In Hospitalised Patients With HIV-Related Advanced Immunosuppression. Am J Respir Crit Care Med 183:A5313, 2011.
35. Small PM, Pai M. Tuberculosis diagnosis-time for a game change. N Engl J Med 363(11):1070-1071, 2010.
36. Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, Ramsay A, Hopewell PC, Pai M. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 8(8):e1001062, 2011.
37. Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther 5(3):327-331, 2007.
38. Treatment Action Group & Stop TB Partnership. Tuberculosis Research and Development: 2011 Report on Tuberculosis Research Funding Trends, 2005-2010. Treatment Action Group, New York, New York, USA, 2011.
39. Usdin M, Guillerm M, Calmy A. Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J Infect Dis 201(Suppl 1):S73-S77, 2010.
40. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375(9729):1920-1937, 2010.
41. Weyer K, Carai S, Nunn P. Viewpoint TB Diagnostics: What does the world really need?. J Infect Dis 204(Suppl 4):S1196-S1202, 2011.
42. Wilson P, Palriwala A. Prizes for Global Health Technologies. Results for Development Institute, Washington, D.C., USA, 2011.
43. WHO. Global Plan to Stop Tuberculosis 2011-2015. World Health Organization, Geneva, Switzerland, 2010.
44. WHO. Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement. 2011a. http://whqlibdoc.who.int/publications/2011/978924150 1613_eng.pdf. (Accessed Oct. 31, 2011.)
45. WHO. Global Tuberculosis Control 2011. World Health Organization, Geneva, Switzerland, 2011b.
46. WHO. Policy Statement: Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. World Health Organization, Geneva, Switzerland, 2011c.
47. WHO. Policy Statement: Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. World Health Organization, Geneva, Switzerland, 2011d.
48. WHO. Same-day diagnosis of tuberculosis by microscopy: policy statement. 2011e. http://whqlibdoc.who. int/publications/2011/9789241501606_eng.pdf. (Accessed Oct. 31, 2011.)
49. WHO. WHO prequalification of diagnostics programme. 2011f. http://www.who.int/diagnostics_laboratory/evaluations/en/. (Accessed Oct. 27, 2011.)
50. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng 10:107-144, 2008.